125 related articles for article (PubMed ID: 9334891)
1. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice.
Yamazaki C; Hoshino J; Hori Y; Sekiguchi T; Miyauchi S; Mizuno S; Horie K
Jpn J Pharmacol; 1997 Sep; 75(1):97-100. PubMed ID: 9334891
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis.
Tanaka K; Ishihara T; Azuma A; Kudoh S; Ebina M; Nukiwa T; Sugiyama Y; Tasaka Y; Namba T; Ishihara T; Sato K; Mizushima Y; Mizushima T
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L348-60. PubMed ID: 20034962
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of a lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis in mice.
Tamagawa K; Taooka Y; Maeda A; Hiyama K; Ishioka S; Yamakido M
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1279-84. PubMed ID: 10764324
[TBL] [Abstract][Full Text] [Related]
4. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
[TBL] [Abstract][Full Text] [Related]
5. Effect of lecithinized-superoxide dismutase on the rat colitis model induced by dextran sulfate sodium.
Hori Y; Hoshino J; Yamazaki C; Sekiguchi T; Miyauchi S; Mizuno S; Horie K
Jpn J Pharmacol; 1997 May; 74(1):99-103. PubMed ID: 9195304
[TBL] [Abstract][Full Text] [Related]
6. [Development of lecithinized superoxide dismutase as a drug for IPF].
Mizushima T
Yakugaku Zasshi; 2014; 134(1):69-76. PubMed ID: 24389620
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Lecithinized Superoxide Dismutase for the Prevention of Acute Respiratory Distress Syndrome in Animal Models.
Tanaka KI; Tamura F; Sugizaki T; Kawahara M; Kuba K; Imai Y; Mizushima T
Am J Respir Cell Mol Biol; 2017 Feb; 56(2):179-190. PubMed ID: 27668315
[TBL] [Abstract][Full Text] [Related]
8. Production of superoxide and nitric oxide by alveolar macrophages in the bleomycin-induced interstitial pneumonia mice model.
Yamazaki C; Hoshino J; Sekiguchi T; Hori Y; Miyauchi S; Mizuno S; Horie K
Jpn J Pharmacol; 1998 Sep; 78(1):69-73. PubMed ID: 9804064
[TBL] [Abstract][Full Text] [Related]
9. Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity.
Igarashi R; Hoshino J; Ochiai A; Morizawa Y; Mizushima Y
J Pharmacol Exp Ther; 1994 Dec; 271(3):1672-7. PubMed ID: 7996483
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cells as a source of airspace extracellular superoxide dismutase after pulmonary injury.
Tan RJ; Lee JS; Manni ML; Fattman CL; Tobolewski JM; Zheng M; Kolls JK; Martin TR; Oury TD
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):226-32. PubMed ID: 16224105
[TBL] [Abstract][Full Text] [Related]
11. Effect of superoxide dismutase on bleomycin-induced dermal sclerosis: implications for the treatment of systemic sclerosis.
Yamamoto T; Takagawa S; Katayama I; Mizushima Y; Nishioka K
J Invest Dermatol; 1999 Nov; 113(5):843-7. PubMed ID: 10571743
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of lecithinized superoxide dismutase on pulmonary emphysema.
Tanaka K; Tanaka Y; Miyazaki Y; Namba T; Sato K; Aoshiba K; Azuma A; Mizushima T
J Pharmacol Exp Ther; 2011 Sep; 338(3):810-8. PubMed ID: 21665943
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase.
Fattman CL; Chang LY; Termin TA; Petersen L; Enghild JJ; Oury TD
Free Radic Biol Med; 2003 Oct; 35(7):763-71. PubMed ID: 14583340
[TBL] [Abstract][Full Text] [Related]
14. Protection against bleomycin-induced lung injury by IL-18 in mice.
Nakatani-Okuda A; Ueda H; Kashiwamura S; Sekiyama A; Kubota A; Fujita Y; Adachi S; Tsuji Y; Tanizawa T; Okamura H
Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L280-7. PubMed ID: 15792964
[TBL] [Abstract][Full Text] [Related]
15. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice.
Li Y; Azuma A; Takahashi S; Usuki J; Matsuda K; Aoyama A; Kudoh S
Chest; 2002 Dec; 122(6):2137-45. PubMed ID: 12475858
[TBL] [Abstract][Full Text] [Related]
16. Attenuation effects of heparin-superoxide dismutase conjugate on bleomycin-induced lung fibrosis in vivo and radiation-induced inflammatory cytokine expression in vitro.
Liu J; Wang X; Wang F; Teng L; Cao J
Biomed Pharmacother; 2009 Aug; 63(7):484-91. PubMed ID: 18602243
[TBL] [Abstract][Full Text] [Related]
17. Novel pharmacological effects of lecithinized superoxide dismutase on ischemia/reperfusion injury in the kidneys of mice.
Tanaka KI; Shimoda M; Kubota M; Takafuji A; Kawahara M; Mizushima T
Life Sci; 2022 Jan; 288():120164. PubMed ID: 34822794
[TBL] [Abstract][Full Text] [Related]
18. Lecithinized superoxide dismutase (PC-SOD) improved spinal cord injury-induced motor dysfunction through suppression of oxidative stress and enhancement of neurotrophic factor production.
Takenaga M; Ohta Y; Tokura Y; Hamaguchi A; Nakamura M; Okano H; Igarashi R
J Control Release; 2006 Jan; 110(2):283-289. PubMed ID: 16332351
[TBL] [Abstract][Full Text] [Related]
19. Interactions of lecithinized superoxide dismutase with serum proteins and cells.
Ishihara T; Nara S; Mizushima T
J Pharm Sci; 2014 Jul; 103(7):1987-1994. PubMed ID: 24867597
[TBL] [Abstract][Full Text] [Related]
20. Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia.
Kawashima T; Wakabayashi T; Kuroda T; Nishide T; Matsuzawa Y; Shirai K
Respirology; 2010 Nov; 15(8):1261-5. PubMed ID: 20920130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
